Am J Health Syst Pharm. 2007;64(9):931-936. These favorable effects on cardiovascular surrogate endpoints highlight the TZDs' potential to affect the progression of diabetes and cardiovascular disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback